Literature DB >> 18666373

Clinical trials are often false positive: a review of simple methods to control this problem.

Ton J Cleophas1, Aeilko H Zwinderman.   

Abstract

BACKGROUND: Statistical hypothesis testing is much like gambling. If, with one statistical test, your chance of a significant result is 5%, then, after 20 tests, it will increase to 40%. This result is based on the play of chance. In current clinical trials, instead of a single efficacy-variable of one treatment, multiple efficacy-variables of more than one treatment are increasingly assessed.
METHODS: The current paper reviews some methods for reducing the problem of falsely positive results due to multiple testing. RESULTS AND
CONCLUSIONS: These methods include (1) the Bonferroni test, (2) the least significant difference (LSD) test, (3) other less conservative, more rarely used methods like Tukey's honestly significant difference (HSD) test, Dunnett's test, Student-Neuman-Keuls test, Hochberg's adjustment, and the Hotelling Q-square test. Alternative approaches to the problem of multiple testing include (4) the construct of composite endpoints, (5) no adjustment at all, but a more philosophical approach to the interpretation of the p-values, and (6) the replacement of the traditional 5% rejection level with a 1% rejection level or less. Evidence-based medicine is under pressure, because trials do not adequately apply to their target populations. As long as the effects of multiple testing are not routinely assessed in the analysis of clinical trials, it can not be excluded as one of the mechanisms responsible.

Entities:  

Mesh:

Year:  2006        PMID: 18666373     DOI: 10.2174/157488406775268228

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  11 in total

1.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Reporting statistics in clinical trials published in Indian journals: a survey.

Authors:  Goyal Jaykaran; N D Kantharia; Y Preeti; P Bharddwaj; J Goyal
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

3.  Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Edward Wang; Robert K Ryu; Ahsun Riaz; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Talia Baker; Michael Abecassis; Al B Benson; Mary F Mulcahy; Reed A Omary; Riad Salem
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

4.  Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.

Authors:  Khairuddin Memon; Laura M Kulik; Robert J Lewandowski; Edward Wang; Jonathan Wang; Robert K Ryu; Ryan Hickey; Michael Vouche; Talia Baker; Daniel Ganger; Vanessa L Gates; Ali Habib; Mary F Mulcahy; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2014-03-07       Impact factor: 3.464

5.  Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Karen Marshall; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Michael Abecassis; Al B Benson; Mary F Mulcahy; Reed A Omary; Riad Salem
Journal:  Gastroenterology       Date:  2011-04-30       Impact factor: 22.682

6.  Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.

Authors:  Robert J Lewandowski; Khairuddin Memon; Mary F Mulcahy; Ryan Hickey; Karen Marshall; Melissa Williams; Krystina Salzig; Vanessa L Gates; Bassel Atassi; Michael Vouche; Rohi Atassi; Kush Desai; Elias Hohlastos; Kent Sato; Ali Habib; Sheetal Kircher; Steven B Newman; Halla Nimeiri; Al B Benson; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-07       Impact factor: 9.236

7.  Systemic responses of preterm newborns with presumed or documented bacteraemia.

Authors:  Alan Leviton; T Michael O'Shea; Francis J Bednarek; Elizabeth N Allred; Raina N Fichorova; Olaf Dammann
Journal:  Acta Paediatr       Date:  2011-12-07       Impact factor: 2.299

8.  The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidence.

Authors:  Mariusz Maziarz; Adrian Stencel
Journal:  Hist Philos Life Sci       Date:  2022-10-18       Impact factor: 1.452

9.  Assess the effects of culturally relevant intervention on breast cancer knowledge, beliefs, and mammography use among Korean American women.

Authors:  Jin Hee Kim; Usha Menon; Edward Wang; Laura Szalacha
Journal:  J Immigr Minor Health       Date:  2009-04-17

10.  Suggested statistical reporting guidelines for clinical trials data.

Authors:  Jaykaran Charan; Deepak Saxena
Journal:  Indian J Psychol Med       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.